Status:
COMPLETED
Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic
Lead Sponsor:
University Hospital, Ghent
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
ONCOVID is a prospective cohort study investigating oncology-patient-reported anxiety, mood, and quality of life during the COVID-19 pandemic. Participants complete a survey consisting of sociodemogra...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Histologically confirmed cancer
- Receive systemic therapy (including chemotherapy, targeted small-molecule therapy, anticancer monoclonal antibody, immunotherapy, endocrine therapy, or investigational agent) (either exclusively or in combination with other anticancer therapy) between February 14, 2020 and March 31, 2020 (Note: Patients whose systemic treatment administration was initially planned for this period but was modified, delayed, stopped, or withheld due to COVID-19 measures are also eligible for inclusion)
Exclusion
- Insufficient understanding of the Dutch language
- Severe cognitive impairment
- Acute psychiatric crisis
- Not able to give informed consent
- Confirmed or clinically suspected COVID-19
- Endocrine therapy in (neo)adjuvant setting (Note: Patients whose (neo)adjuvant systemic treatment was initially planned as chemotherapy, targeted small-molecule therapy, anticancer monoclonal antibody, immunotherapy, or investigational agent (either exclusively or in combination in combination with other anticancer therapy) but was modified to endocrine therapy due to COVID-19 measures are also eligible for inclusion)
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 18 2020
Estimated Enrollment :
394 Patients enrolled
Trial Details
Trial ID
NCT04340219
Start Date
March 30 2020
End Date
September 18 2020
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Gent
Ghent, Belgium, 9000